Barbara Withers
Director Técnico/Científico/I+D en OCUPHIRE PHARMA, INC. .
Perfil
Barbara Withers is currently the VP-Clinical & Regulatory Strategy at Ocuphire Pharma, Inc. Previously, she worked as a Project Director & Site Head at United BioSource Corp., a Project Manager-Drug Development at Pfizer Inc., and a Vice President-Clinical Operations at Aerpio Pharmaceuticals, Inc. Barbara received her undergraduate degree from the University of Michigan and her doctorate from The Wayne State University School of Medicine.
Cargos activos de Barbara Withers
| Empresas | Cargo | Inicio |
|---|---|---|
| OCUPHIRE PHARMA, INC. | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Barbara Withers.
| Empresas | Cargo | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
United BioSource Corp.
 United BioSource Corp. Miscellaneous Commercial ServicesCommercial Services United BioSource Corp. is a scientific and medical affairs organization that partners with life science companies to develop and commercialize their products. The company is involved in pre- and post-approval product development; pricing, coverage, reimbursement, and access strategies; and medical publication and communications. United BioSource Corp. was founded by Ethan D. Leder and Mark P. Cleinin in 2003 and is headquartered in Chevy Chase, MD. | Corporate Officer/Principal | - |
| AERPIO PHARMACEUTICALS | Corporate Officer/Principal | - |
Formación de Barbara Withers.
| The Wayne State University School of Medicine | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| OCUPHIRE PHARMA, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Aerpio Pharmaceuticals, Inc.
 Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. The firm's product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company was founded by Joseph H. Garder on November 16, 2007 and is headquartered in Cincinnati, OH. | Health Technology |
United BioSource Corp.
United BioSource Corp. Miscellaneous Commercial ServicesCommercial Services United BioSource Corp. is a scientific and medical affairs organization that partners with life science companies to develop and commercialize their products. The company is involved in pre- and post-approval product development; pricing, coverage, reimbursement, and access strategies; and medical publication and communications. United BioSource Corp. was founded by Ethan D. Leder and Mark P. Cleinin in 2003 and is headquartered in Chevy Chase, MD. | Commercial Services |
- Bolsa de valores
- Insiders
- Barbara Withers
